Lamivudine treatment in infantile fulminant hepatitis B

Pediatrics International

Volumn 52, Issue 4, 2010, Pages 672-674

  Chen, Ching Yi ^a   Ni, Yen Hsuan ^a   Chen, Huey Ling ^a   Lu, Frank Leigh ^a   Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

fulminant hepatitis B; infantile; lamivudine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FRESH FROZEN PLASMA; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; LAMIVUDINE; VIRUS DNA; VITAMIN K GROUP;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BRAIN DYSFUNCTION; CASE REPORT; CONSCIOUSNESS DISORDER; DECREASED APPETITE; DROWSINESS; ELECTROENCEPHALOGRAM; ERYTHROCYTE CONCENTRATE; EXCHANGE BLOOD TRANSFUSION; FEVER; FOLLOW UP; FULMINANT HEPATIC FAILURE; GENOTYPE; HEPATITIS B; HUMAN; HYPERAMMONEMIA; HYPERREFLEXIA; HYPOGLYCEMIA; INFANT; INFANT DISEASE; JAUNDICE; LIVER FAILURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTHROMBIN TIME; SOMNOLENCE; STUPOR; TANDEM MASS SPECTROMETRY; URINALYSIS; VIRUS REPLICATION;

ANTIVIRAL AGENTS; HEPATITIS B; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LAMIVUDINE; LIVER FAILURE, ACUTE; MALE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 77955787946     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03110.x     Document Type: Article

References (10)

1. Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis in children in Taiwan: The important role of hepatitis B virus. J. Pediatr. 1987 111 : 34 9.
2. Tillmann HL, Hadem J, Leifeld L et al. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J. Viral Hepat. 2006 13 : 256 63.
3. Laubscher B, Gehri M, Roulet M, Wirth S, Gerner P. Survival of infantile fulminant hepatitis B and treatment with lamivudine. J. Pediatr. Gastroenterol. Nutr. 2005 40 : 518 20.
4. Chan PC, Chen HL, Kong MS et al. Factors affecting the mortality of pediatric fulminant hepatic failure in relation to hepatitis B virus infection. J. Gastroenterol. Hepatol. 2005 20 : 1223 7.
5. Hsu HY, Chang MH, Hsieh KH et al. Cellular immune response to hepatitis B core antigen in maternal-infant transmission of hepatitis B virus. Hepatology 1992 15 : 770 6.
6. Ni YS, Huang LM, Chen DS et al. Two decades of universal hepatitis B vaccination in Taiwan: Impact and implication for further strategies. Gastroenterolog 2007 132 : 1287 93.
7. Chen HL, Ni YH, Chang MH et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 2004 39 : 58 63.
8. Jonas MM, Mizerski J, Badia IB et al. Clinical trial of lamivudine in children with chronic hepatitis B. N. Engl. J. Med. 2002 346 : 1706 13.
9. Friedt M, Gerner P, Lausch E, Trübel H, Zabel B, Wirth S. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 1999 29 : 1252 8.
10. Ni YH, Huang FC, Wu TC et al. Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients. Pediatr. Int. 2005 47 : 372 7.